Abstract
The use of genetically engineered mice to understand gene function is widespread. Changes to the mouse genome can be introduced with gene targeting vectors or with transgenes. Targeting vectors are usually used to ablate gene expression while transgenes are designed to express proteins that are normally absent from the organism. For example, gene targeting in mouse embryonic stem cells can be used to generate a mutant mouse model that fails to express a physiologically important protein. Transgenes that express the missing protein or a substitute for the missing protein can be used to assess possible gene therapies for the mutant mouse. Both gene targeting and transgene approaches can be used to study regulatory elements that control gene function. Putative control elements can be added to or removed from the chromosome with targeting vectors. Transgenes carrying long DNA sequences that include different combinations of potential control elements can be introduced into the genome to assess their effects on gene expression. The exploration of how genes interact to control development, homeostasis, and pathophysiological conditions can be dissected by introducing carefully designed genetic constructs into model organisms.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- BAC:
-
Bacterial artificial chromosome
- ES cell:
-
Embryonic stem cell
- IKMC:
-
International Mouse Knockout Consortium
- Kb:
-
Kilo base pairs of DNA
- PGKneo:
-
DNA cassette featuring neomycin phosphotransferase II expression controlled by the phosphoglycerol kinase 1 promoter/enhancer
- ZFN:
-
Zinc finger nuclease
References
Tybulewicz VLJ, Crawford CE, Jackson PK, Bronson PT, Mulligan RC (1991) Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65:1153–1163
Zijlstra M, Li E, Sajjadi F, Subramani S, Jaenisch R (1989) Germ-line transmission of a disrupted beta 2-microglobulin gene produced by homologous recombination in embryonic stem cells. Nature 342(6248):435–438
Gu H, Marth JD, Orban PC, Mossmann H, Rajewsky K (1994) Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science 265(5168):103–106
Orban PC, Chui D, Marth JD (1992) Tissue- and site-specific DNA recombination in transgenic mice. Proc Natl Acad Sci USA 89(15):6861–6865
Kühn R, Schwenk F, Aguet M, Rajewsky K (1995) Inducible gene targeting in mice. Science 269:1427–1429
Feil R, Brocard J, Mascrez B, LeMeur M, Metzger D, Chambon P (1996) Ligand-activated site-specific recombination in mice. Proc Natl Acad Sci USA 93:10887–10890
Furth PA, St Onge L, Böger H, Gruss P, Gossen M, Kistner A, Bujard H, Hennighausen L (1994) Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci USA 91:9302–9306
Nagy A, Moens C, Ivanyi E, Pawling J, Gertsenstein M, Hadjantonakis AK, Pirity M, Rossant J (1998) Dissecting the role of N-myc in development using a single targeting vector to generate a series of alleles. Curr Biol 8:661–664
Le Mouellic H, Lallemand Y, Brûlet P (1992) Homeosis in the mouse induced by a null mutation in the Hox-3.1 gene. Cell 69:251–264
Ikawa M, Kominami K, Yoshimura Y, Tanaka K, Nishimune Y, Okabe M (1995) A rapid and non-invasive selection of transgenic embryos before implantation using green fluorescent protein (GFP). FEBS Lett 375:125–128
Livet J, Weissman TA, Kang H, Draft RW, Lu J, Bennis RA, Sanes JR, Lichtman JW (2007) Transgenic strategies for combinatorial expression of fluorescent proteins in the nervous system. Nature 450(7166):56–62
Cretekos CJ, Wang Y, Green ED, Martin JF, Rasweiler JJ 4th, Behringer RR (2008) Regulatory divergence modifies limb length between mammals. Genes Dev 22:141–151
Hanks MC, Loomis CA, Harris E, Tong CX, Anson-Cartwright L, Auerbach A, Joyner A (1998) Drosophila engrailed can substitute for mouse Engrailed1 function in mid-hindbrain, but not limb development. Development 125:4521–4530
Zou YR, Gu H, Rajewsky K (1993) Generation of a mouse strain that produces immunoglobulin kappa chains with human constant regions. Science 262:1271–1274
Schnütgen F, De-Zolt S, Van Sloun P, Hollatz M, Floss T, Hansen J, Altschmied J, Seisenberger C, Ghyselinck NB, Ruiz P, Chambon P, Wurst W, von Melchner H (2005) Genomewide production of multipurpose alleles for the functional analysis of the mouse genome. Proc Natl Acad Sci USA 102:7221–7226
Anastassiadis K, Fu J, Patsch C, Hu S, Weidlich S, Duerschke K, Buchholz F, Edenhofer F, Stewart AF (2009) Dre recombinase, like Cre, is a highly efficient site-specific recombinase in E. coli, mammalian cells and mice. Dis Model Mech 2:508–515
Raymond CS, Soriano P (2007) High-efficiency FLP and PhiC31 site-specific recombination in mammalian cells. PLoS ONE 2:e162
Osterwalder M, Galli A, Rosen B, Skarnes WC, Zeller R, Lopez-Rios J (2010) Dual RMCE for efficient re-engineering of mouse mutant alleles. Nat Methods. doi:10.1038/nmeth.1521
Singla V, Hunkapiller J, Santos N, Seol AD, Norman AR, Wakenight P, Skarnes WC, Reiter JF (2010) Floxin, a resource for genetically engineering mouse ESCs. Nat Methods 7:50–52
Araki K, Araki M, Miyazaki J-I, Vassalli P (1995) Site-specific recombination of a transgene in fertilized eggs by transient expression of Cre recombinase. Proc Natl Acad Sci USA 92:160–164
Schaft J, Ashery Padan R, van der Hoeven F, Gruss P, Stewart AF (2001) Efficient FLP recombination in mouse ES cells and oocytes. Genesis 31:6–10
te Riele H, Maandag ER, Berns A (1992) Highly efficient gene targeting in embryonic stem cells through homologous recombination with isogenic DNA constructs. Proc Natl Acad Sci USA 89:5128–5132
van Deursen J, Wieringa B (1992) Targeting of the creatine kinase M gene in embryonic stem cells using isogenic and nonisogenic vectors. Nucleic Acids Res 20:3815–3820
Zhou L, Rowley DL, Mi QS, Sefcovic N, Matthes HW, Kieffer BL, Donovan DM (2001) Murine inter-strain polymorphisms alter gene targeting frequencies at the mu opioid receptor locus in embryonic stem cells. Mamm Genome 12:772–778
Hasty P, Abuin A, Bradley A (2000) Gene targeting, principles, and practice in mammalian cells. In: Joyner AL (ed) Gene targeting: a practical approach, 2nd edn. Oxford University Press, London, pp 1–35
Friedel RH, Plump A, Lu X, Spilker K, Jolicoeur C, Wong K, Venkatesh TR, Yaron A, Hynes M, Chen B, Okada A, McConnell SK, Rayburn H, Tessier-Lavigne M (2005) Gene targeting using a promoterless gene trap vector (“targeted trapping”) is an efficient method to mutate a large fraction of genes. Proc Natl Acad Sci USA 102:13188–13193
George SH, Gertsenstein M, Vintersten K, Korets-Smith E, Murphy J, Stevens ME, Haigh JJ, Nagy A (2007) Developmental and adult phenotyping directly from mutant embryonic stem cells. Proc Natl Acad Sci USA 104:4455–4460
Ioffe E, Liu Y, Bhaumik M, Poirier F, Factor SM, Stanley P (1995) WW6: an embryonic stem cell line with an inert genetic marker that can be traced in chimeras. Proc Natl Acad Sci USA 92:7357–7361
Poueymirou WT, Auerbach W, Frendewey D, Hickey JF, Escaravage JM, Esau L, Dore’ AT, Stevens S, Adams NC, Dominguez MG, Gale NW, Yancopoulos GD, DeChiara TM, Valenzuela DM (2007) Nat Biotechnol 25:91–99
Valenzuela DM, Murphy AJ, Frendewey D, Gale NW, Economides AN, Auerbach W, Poueymirou WT, Adams NC, Rojas J, Yasenchak J, Chernomorsky R, Boucher M, Elsasser AL, Esau L, Zheng J, Griffiths JA, Wang X, Su H, Xue Y, Dominguez MG, Noguera I, Torres R, Macdonald LE, Stewart AF, DeChiara TM, Yancopoulos GD (2003) High-throughput engineering of the mouse genome coupled with high-resolution expression analysis. Nat Biotechnol 21:652–659
Thomas KR, Capecchi MR (1987) Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51:503–512
Meyers EN, Lewandoski M, Martin GR (1998) An Fgf8 mutant allelic series generated by Cre- and Flp- mediated recombination. Nat Genet 18:136–141
Jacks T, Shih TS, Scmitt EA, Bronson RT, Bernards A, Weinberg RA (1994) Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nat Genet 7:353–361
Scacheri PC, Crabtree JS, Novotny EA, Garrett-Beal L, Chen A, Edgemon KA, Marx SJ, Spiegel AM, Chandrasekharappa SC, Collins FS (2001) Bidirectional transcriptional activity of PGK-neomycin and unexpected embryonic lethality in heterozygote chimeric knockout mice. Genesis 30:259–263
Crabtree JS, Scacheri PC, Ward JM, Garrett-Beal L, Emmert-Buck MR, Edgemon KA, Lorang D, Libutti SK, Chandrasekharappa SC, Marx SJ, Spiegel AM, Collins FS (2001) A mouse model of multiple endocrine neoplasia, type1, develops multiple endocrine tumors. Proc Natl Acad Sci USA 98:1118–1123
Zhu Y, Romero MI, Ghosh P, Ye Z, Charnay P, Rushing EJ, Marth JD, Parada LF (2001) Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain. Genes Dev 15:859–876
Shavit JA, Motohashi H, Onodera K, Akasaka J, Yamamoto M, Engel JD (1998) Impaired megakaryopoiesis and behavioral defects in mafG-null mutant mice. Genes Dev 12:2164–2174
Hedges SJ, Deininger PL (2007) Inviting instability: transposable elements, double-strand breaks, and the maintenance of genome integrity. Mutat Res 616:46–59
Horie K, Saito ES, Keng VW, Ikeda R, Ishihara H, Takeda J (2007) Retrotransposons influence the mouse transcriptome: implication for the divergence of genetic traits. Genetics 176:815–827
Richard GF, Kerrest A, Dujon B (2008) Comparative genomics and molecular dynamics of DNA repeats in eukaryotes. Microbiol Mol Biol Rev 72:686–727
Kang YK, Park JS, Lee CS, Yeom YI, Chung AS, Lee KK (1999) Efficient integration of short interspersed element-flanked foreign DNA via homologous recombination. J Biol Chem 274:36585–36591
Konkel MK, Batzer MA (2010) A mobile threat to genome stability: the impact of non-LTR retrotransposons upon the human genome. Semin Cancer Biol 20:211–221
McVean G (2010) What drives recombination hotspots to repeat DNA in humans? Philos Trans R Soc Lond B Biol Sci 365:1213–1218
Yagi T, Ikawa Y, Yoshida K, Shigetani Y, Takeda N, Mabuchi I, Yamamoto T, Aizawa S (1990) Homologous recombination at c-fyn locus of mouse embryonic stem cells with use of diphtheria toxin A-fragment gene in negative selection. Proc Natl Acad Sci USA 87:9918–9922
Skarnes WC (2005) Two ways to trap a gene in mice. Proc Natl Acad Sci USA 89:5128–5132
Belteki G, Gertsenstein M, Ow DW, Nagy A (2003) Site specific cassette exchange and germline transmission with mouse ES cells expressing phiC31 integrase. Nat Biotechnol 21:321–324
Kranz A, Fu J, Duerschke K, Weidlich S, Naumann R, Stewart AF, Anastassiadis K (2010) An improved Flp deleter mouse in C57BL/6 based on Flpo recombinase. Genesis 48:512–520
Ohtsuka M, Ogiwara S, Miura H, Mizutani A, Warita T, Sato M, Imai K, Hozumi K, Sato T, Tanaka M, Kimura M, Inoko H (2010) Pronuclear injection-based mouse targeted transgenesis for reproducible and highly efficient transgene expression. Nucleic Acids Res 38:e198
Surzycki S (2000) Basic techniques in molecular biology. Springer, Berlin
Johansson T, Broll I, Frenz T, Hemmers S, Becher B, Zeilhofer HU, Buch T (2010) Building a zoo of mice for genetic analyses: a comprehensive protocol for the rapid generation of BAC transgenic mice. Genesis 48:264–280
Gong S, Kus L, Heintz N (2010) Rapid bacterial artificial chromosome modification for large-scale mouse transgenesis. Nat Protoc 10:1678–1696
Boffelli D, Nobrega MA, Rubin EM (2004) Comparative genomics at the vertebrate extremes. Nat Rev Genet 5:456–465
Baker KE, Parker R (2004) Nonsense-mediated mRNA decay: terminating erroneous gene expression. Curr Opin Cell Biol 16:293–299
Joyner AL, Skarnes WC, Rossant J (1989) Production of a mutation in mouse En-2 gene by homologous recombination in embryonic stem cells. Nature 338:153–156
McMahon AP, Bradley A (1990) The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain. Cell 62:1073–1085
Ginzinger DG (2002) Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. Exp Hematol 30:503–512
Soliman GA, Ishida-Takahashi R, Gong Y, Jones JC, Leshan RL, Saunders TL, Fingar DC, Myers MG Jr (2007) A simple qPCR-based method to detect correct insertion of homologous targeting vectors in murine ES cells. Transgenic Res 16:665–670
Friedel RH, Seisenberger C, Kaloff C, Wurst W (2007) EUCOMM–the European conditional mouse mutagenesis program. Brief Funct Genomic Proteomic 6:180–185
Chan W, Costantino N, Li R, Lee SC, Su Q, Melvin D, Court DL, Liu P (2007) A recombineering based approach for high-throughput conditional knockout targeting vector construction. Nucleic Acids Res 35:e64
Testa G, Zhang Y, Vintersten K, Benes V, Pijnappel WW, Chambers I, Smith AJ, Smith AG, Stewart AF (2003) Engineering the mouse genome with bacterial artificial chromosomes to create multipurpose alleles. Nat Biotechnol 21:443–447
Saunders TL (2010) A survey of internet resources for mouse development. Meth Enzymol 476:3–21
Eitzman DT, Westrick RJ, Shen Y, Bodary PF, Gu S, Manning SL, Dobies SL, Ginsburg D (2005) Homozygosity for factor V Leiden leads to enhanced thrombosis and atherosclerosis in mice. Circulation 111:1822–1825
Huang X, Fu Y, Charbeneau RA, Neubig RR (2009) GNAI2 and regulators of G protein signaling as a potential Noonan syndrome mechanism. Med Hypotheses 73:56–59
Elia L, Quintavalle M, Zhang J, Contu R, Cossu L, Latronico MV, Peterson KL, Indolfi C, Catalucci D, Chen J, Courtneidge SA, Condorelli G (2009) The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ 16:1590–1598
Visel A, Zhu Y, May D, Afzal V, Gong E, Attanasio C, Blow MJ, Cohen JC, Rubin EM, Pennacchio LA (2010) Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice. Nature 464:409–412
Olson LE, Richtsmeier JT, Leszl J, Reeves RH (2004) A chromosome 21 critical region does not cause specific Down syndrome phenotypes. Science 306:687–690
Tybulewicz VL, Fisher EM (2006) New techniques to understand chromosome dosage: mouse models of aneuploidy. Hum Mol Genet 15 Spec No 2:R103–R109
Carbery ID, Ji D, Harrington A, Brown V, Weinstein EJ, Liaw L, Cui X (2010) Targeted genome modification in mice using zinc-finger nucleases. Genetics 186:451–459
Cui X, Ji D, Fisher DA, Wu Y, Briner DM, Weinstein EJ (2011) Targeted integration in rat and mouse embryos with zinc-finger nucleases. Nat Biotechnol 29:64–67
Meyer M, de Angelis MH, Wurst W, Kühn R (2010) Gene targeting by homologous recombination in mouse zygotes mediated by zinc-finger nucleases. Proc Natl Acad Sci USA 107:15022–15026
Swiatek PJ, Gridley T (1993) Perinatal lethality and defects in hindbrain development in mice homozygous for a targeted mutation of the zinc finger gene Krox20. Genes Dev 7:2071–2084
Doetschman TC, Eistetter H, Katz M, Schmidt W, Kemler R (1985) The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood island and myocardium. J Embryol Exp Morph 87:27–45
Hooper M, Hardy K, Handyside A, Hunter S, Monk M (1987) HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells. Nature 326:292–295
Li E, Bestor TH, Jaenisch R (1992) Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69:915–926
Pettitt SJ, Liang Qu, Rairdan XY, Moran JL, Prosser HM, Beier DR, Lloyd KC, Bradley A, Skarnes WC (2009) Agouti C57BL/6N embryonic stem cells for mouse genetic resources. Nat Methods 6:493–495
Domino SE, Zhang L, Gillespie PJ, Saunders TL, Lowe JB (2001) Deficiency of reproductive tract (1,2)fucosylated glycans and normal fertility in mice with targeted deletions of the FUT1 or FUT2 (1,2)fucosyltransferase locus. Mol Cell Biol 21:8336–8345
Deng C, Wynshaw-Boris A, Zhou F, Kuo A, Leder P (1996) Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 84:911–921
Vetter K (2000) Die Funktion von FGF2 und FGF8 während der Entwicklung des Nervensystems in der Maus. Doctoral dissertation, University of Technology, Munich
Rideout WM 3rd, Wakayama T, Wutz A, Eggan K, Jackson-Grusby L, Dausman J, Yanagimachi R, Jaenisch R (2000) Generation of mice from wild-type and targeted ES cells by nuclear cloning. Nat Genet 24:109–110
Auerbach W, Dunmore JH, Fairchild-Huntress V, Fang Q, Auerbach AB, Huszar D, Joyner AL (2000) Establishment and chimera analysis of 129/ SvEv- and C57BL/6-derived mouse embryonic stem cell lines. Biotechniques 29:1024–1032
Araki K, Imaizumi T, Sekimoto T, Yoshinobu K, Yoshimuta J, Akizuki M, Miura K, Araki M, Yamamura K (1999) Exchangeable gene trap using the Cre/mutated lox system. Cell Mol Biol 45:737–750
Cheah SS, Behringer RR (2001) Contemporary gene targeting strategies for the novice. Mol Biotechnol 19:297–304
Hughes ED, Qu YY, Genilk SJ, Lyons RH, Pacheco CD, Lieberman AP, Samuelson LC, Nasonkin IO, Camper SA, Van Keuren ML, Saunders TL (2007) Genetic variation in C57BL/6 ES cell line. Mamm Genome 18:549–558
Kendall SK, Samuelson LC, Saunders TL, Wood RI, Camper SA (1995) Targeted disruption of the pituitary glycoprotein hormone alpha-subunit produces hypogonadal and hypothyroid mice. Genes Dev 9:2007–2019
Martin MS, Dutt K, Papale LA, Dubé CM, Dutton SB, de Haan G, Shankar A, Tufik S, Meisler MH, Baram TZ, Goldin AL, Escayg A (2010) Altered function of the SCN1A voltage-gated sodium channel leads to gamma-aminobutyric acid-ergic (GABAergic) interneuron abnormalities. J Biol Chem 285:9823–9834
Miyaki S, Sato T, Inoue A, Otsuki S, Ito Y, Yokoyama S, Kato Y, Takemoto F, Nakasa T, Yamashita S, Takada S, Lotz MK, Ueno-Kudo H, Asahara H (2010) MicroRNA-140 plays dual roles in both cartilage development and homeostasis. Genes Dev 24:1173–1185
Nagy A, Rossant J, Nagy R, Abramow-Newerly W, Roder JC (1993) Derivation of completely cell culture-derived mice from early-passage stem cells. Proc. Natl. Acad. Sci. U.S.A. 90:8424–8428
Simpson EM, Linder CC, Sargent EE, Davisson MT, Mobraaten LE, Sharp JJ. 1997. Genetic variation among 129 substrains and its importance for targeted mutageneeis in mice. Nat. Genet 16:19–27
Szabó P, Mann JR (1994) Expression and methylation of imprinted genes during in vitro differentiation of mouse parthenogenetic and androgenetic embryonic stem cell lines. Development 120:1651–1660
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this protocol
Cite this protocol
Saunders, T.L. (2011). Gene Targeting Vector Design for Embryonic Stem Cell Modifications. In: Pease, S., Saunders, T. (eds) Advanced Protocols for Animal Transgenesis. Springer Protocols Handbooks. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-20792-1_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-20792-1_4
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-20791-4
Online ISBN: 978-3-642-20792-1
eBook Packages: Springer Protocols